Compare Abbott Laboratories (ABT) vs Global X Autonomous & Electric Vehicles (DRIV) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Global X Autonomous & Electric Vehicles — how do they compare? Abbott Laboratories trades at $94.9 (market cap $166.94B), while Global X Autonomous & Electric Vehicles trades at $35.85. The key difference: Abbott Laboratories pays a 2.63% dividend while Global X Autonomous & Electric Vehicles pays none, and Global X Autonomous & Electric Vehicles is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | DRIV | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Sector/Thematic |
52-Week High | $136.62 | $42.53 |
52-Week Low | $82.57 | $23.67 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
DRIV trades at $37.63, up 2.42% today, but technical signals are bearish with moving averages indicating selling pressure. The stock faces industry headwinds from shifting consumer demand and geopolitical tensions affecting fuel prices. Recent news highlights competitive threats from Chinese EV makers and regulatory uncertainties in the U.S. market, while a dividend of $0.07 is scheduled for July 2026.
Outlook remains cautious due to bearish technicals and sector volatility. Investment opportunities lie in exposure to autonomous driving and EV growth, but risks include intense competition, regulatory changes, and macroeconomic pressures. Wall Street sentiment is mixed, reflecting the ETF's diversified tech and auto holdings amid evolving market dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Global X Autonomous & Electric Vehicles
DRIV invests in companies involved in autonomous driving and electric vehicle production. It tracks the Solactive Autonomous & Electric Vehicles Index, focusing on software and hardware leaders like Tesla, NVIDIA, and Microsoft.
Read more on DRIV →
